Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Health-related quality of life among latinos with multiple sclerosis.
Poly(ADP-ribose) polymerase 2 contributes to neuroinflammation and neurological dysfunction in mouse experimental autoimmune encephalomyelitis.
RANTES and fibroblast growth factor 2 in jawbone cavitations: triggers for systemic disease?
Seronegative NMO: A sensitive AQP4 antibody test clarifies clinical features and next challenges.
Charcot-Marie-Tooth disease: Frequency of genetic subtypes in a German neuromuscular center population.
Type D, anxiety and depression in association with quality of life in patients with Parkinson's disease and patients with multiple sclerosis.
Preventive treatment with methylprednisolone paradoxically exacerbates experimental autoimmune encephalomyelitis.
CD21 positive B cell: A novel target for treatment of multiple sclerosis.
Effect of interferon beta-1a on B7.1 and B7.2 B-cell expression and its impact on T-cell proliferation.
Stem cell therapy independent of stemness.
Risk factors for falls in multiple sclerosis: an observational study.
Induction Therapy for Patients with Multiple Sclerosis: Why? When? How?
Bone mineral density and body composition in men with multiple sclerosis chronically treated with low-dose glucocorticoids.
Role of Formyl Peptide Receptors (FPR) in Abnormal Inflammation Responses Involved in Neurodegenerative Diseases.
Targeting ion channels for the treatment of autoimmune neuroinflammation.
Advances in understanding the pathogenesis of autoimmune disorders: focus on chemokines and lymphocyte trafficking.
An overview of the molecular mechanisms and novel roles of Nrf2 in neurodegenerative disorders.
MS risk allele rs1883832T is associated with decreased mRNA expression of CD40.
Induction of oxiapoptophagy on 158N murine oligodendrocytes treated by 7-ketocholesterol-, 7β-hydroxycholesterol-, or 24(S)-hydroxycholesterol: Protective effects of α-tocopherol and docosahexaenoic acid (DHA; C22:6 n-3).
Identification of cortical lesions using DIR and FLAIR in early stages of multiple sclerosis.
Aptamer Oligonucleotides: Novel Potential Therapeutic Agents in Autoimmune Disease.
The unfolded protein response in multiple sclerosis.
[Concepts and epidemiology of combined central and peripheral demyelination].
Oral treatment with the herbal formula B401 protects against aging-dependent neurodegeneration by attenuating oxidative stress and apoptosis in the brain of R6/2 mice.
Validity of Maximal Exercise Testing in Patients With Low to Moderate Multiple Sclerosis.

Pages